Drug intelligence / Profile preview

colquhounia root tablet

Development stage
Phase 4
Modality
Small Molecules
Administration
Oral
01

Overview

Colquhounia root tablet (CRT) is a traditional Chinese patent medicine prepared from the peeled root of Tripterygium hypoglaucum. It has been used for decades in China to treat autoimmune and inflammatory diseases, particularly chronic glomerulopathy and diabetic kidney disease. CRT exhibits anti-inflammatory, immunosuppressive, and analgesic properties. Its mechanisms of action include modulation of immune pathways such as Th17 cell differentiation and C-type lectin receptor signaling; inhibition of the PI3K/AKT pathway via upregulation of PTEN; suppression of CD36 expression; activation of AMPK signaling; promotion of autophagy; and inhibition of apoptosis in renal tissues. Clinical studies have shown that CRT significantly reduces proteinuria in patients with chronic glomerulopathy (including IgA nephropathy, membranous nephropathy, and diabetic kidney disease), with a favorable safety profile[1][3][8].

Brand names
Huobahuagen
Other names
CRTTripterygium hypoglaucum root tabletChinese patent medicine from Tripterygium hypoglaucum
02

Targets

AKT1 (Proto-oncogene serine/threonine-protein kinase Akt1)AMPK (Adenosine monophosphate–activated protein kinase)CD36 (CD36 antigen)IL1B (Interleukin-1 beta)IL-6 (Interleukin 6)PI3K (Phosphoinositide-3-kinase regulatory subunit 6)PTEN (Phosphatase and tensin homolog deleted on chromosome ten)TNFA (Tumor necrosis factor alpha (soluble))AKT (RAC-alpha serine/threonine-protein kinase)

Beyond the preview

Go deeper on colquhounia root tablet.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on colquhounia root tablet.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call